Scarica l'app Stockscreener
213.00
0.54%
1.14
Dopo l'orario di chiusura:
212.46
-0.54
-0.25%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ABBV Giù?
Forum
Previsione
Storia dei dividendi
Abbvie Inc Borsa (ABBV) Ultime notizie
Genmab/AbbVie’s Epkinly Could Get Competitive Edge With Outpatient Option - insights.citeline.com
AbbVie Beats Employee’s Would-Be Whistleblower Suit on Appeal - Bloomberg Law News
Will AbbVie Inc. bounce back from current supportEarnings Risk Summary & High Accuracy Trade Signal Alerts - Newser
Multiple Myeloma Market Size Projected USD 49.89 Billion by 2034 - GlobeNewswire Inc.
AbbVie updates mid-stage trial data for Genmab-partnered lymphoma drug in outpatient setting - Seeking Alpha
AbbVie reports positive results for outpatient lymphoma treatment - Investing.com
AbbVie Announces Updated Results From Phase 2 EPCORE® NHL-6 Study Evaluating the Potential for Outpatient Monitoring of Epcoritamab in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma - Investing News Network
AbbVie Announces Updated Results From Phase 2 EPCORE® NHL-6 Study Evaluating the Potential for Outpatient Monitoring of Epcoritamab in Patients With Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) - PR Newswire
Allergan Aesthetics Launches Campaign to Educate Consumers about Hyaluronic Acid (HA) Injectable Fillers - AbbVie News Center
Intraday pattern recognizer results for AbbVie Inc.Market Trend Report & Verified Stock Trade Ideas - Newser
Stock Analysis | Abbvie OutlookMixed Signals Amid Optimistic Analysts and Strong Fundamentals - AInvest
Quantitative breakdown of AbbVie Inc. recent moveTrade Signal Summary & Daily Profit Maximizing Tips - Newser
Combining machine learning predictions for AbbVie Inc.Stop Loss & Fast Gaining Stock Strategy Reports - Newser
AbbVie’s Strategic Acquisitions and Trial Success Fuel 0.72% Rally Despite 102nd-Ranked 920M Volume - AInvest
Strategic Implications of AbbVie’s Elahere Approval in Canada: A New Era for Oncology Growth and Market Access - AInvest
AbbVie's Elahere gains approval in Canada for ovarian cancer - Seeking Alpha
Visual trend scoring systems applied to AbbVie Inc.Trade Entry Summary & Real-Time Buy Zone Alerts - Newser
AbbVie HIV Drugs Being Tested as Possible Coronavirus Antidote - TheStreet
AbbVie to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference - Investing News Network
Candlestick signals on AbbVie Inc. stock today2025 Trade Ideas & Fast Gain Swing Alerts - Newser
AbbVie Inc. (ABBV) Acquires Psychedelic Drug Developer Gilgamesh for $1.2B, Enters Mental Health Market - MSN
Explore the human side of the health journey in AbbVie’s I Am campaign - Medical Marketing and Media
Visual analytics tools that track AbbVie Inc. performanceFed Meeting & Real-Time Sentiment Analysis - Newser
AbbVie to invest $195 million in new North Chicago pharmaceutical facility - Chicago Construction News
AbbVie (ABBV) Stock Analysis: Price Target & Market OutlookNews and Statistics - IndexBox
Is AbbVie Inc. backed by strong institutional buyingInsider Buying & AI Enhanced Market Trend Forecasts - خودرو بانک
Is AbbVie Stock Underperforming the S&P 500? - MSN
How to escape a deep drawdown in AbbVie Inc.2025 Big Picture & Real-Time Price Movement Reports - Newser
Analyzing recovery setups for AbbVie Inc. investorsGDP Growth & Fast Gain Stock Trading Tips - Newser
Analyzing drawdowns of AbbVie Inc. with statistical toolsTrade Exit Summary & Verified Stock Trade Ideas - Newser
Why AbbVie's Workplace Excellence Drives Long-Term Value for Investors - AInvest
Key metrics from AbbVie Inc.’s quarterly dataInflation Watch & Target Return Focused Picks - Newser
AbbVie Named to 2025 Best Workplaces in Asia List by Great Place To Work - Yahoo Finance
What indicators show strength in AbbVie Inc.2025 Retail Activity & Verified Entry Point Signals - Newser
What recovery options are there for AbbVie Inc.2025 Stock Rankings & Smart Money Movement Tracker - Newser
Pharma and Industrial Sector Catalysts: Evaluating AbbVie and Hawkins' Strategic Momentum - AInvest
What machine learning models say about AbbVie Inc.Weekly Trend Summary & Real-Time Stock Price Movement Reports - Newser
Signal strength of AbbVie Inc. stock in tech scannersMarket Volume Summary & Free Verified High Yield Trade Plans - Newser
Tools to assess AbbVie Inc.’s risk profile2025 Top Gainers & Technical Pattern Based Signals - Newser
Key deals this week: Hawkins, Canada Goose, AbbVie, Verint and more (BX:NYSE) - Seeking Alpha
Is AbbVie Inc. trending in predictive chart models2025 Performance Recap & Reliable Intraday Trade Plans - Newser
Is AbbVie Stock Underperforming The S&P 500? - Barchart.com
BeOne Preps For Sonrotoclax MCL Filing, With Sights Set On AbbVie/Roche’s Territory - insights.citeline.com
Detecting price anomalies in AbbVie Inc. with AIWeekly Risk Summary & Reliable Volume Spike Trade Alerts - Newser
0.43%
0.15%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):